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Amyloid beta peptides inhibit learning, but how they do so is unclear. Zhao et al. demonstrate Ab blocks learning by inhibiting synapse assembly via the NgR family. Ab-NgR signaling inhibits synaptogenesis by blocking T-type calcium channels.
INTRODUCTION
Among the leading causes of death in the United States, only Alzheimer's disease (AD) remains without treatments. Research has identified some primary culprits driving AD pathology, chief among them amyloid beta (Ab) peptides (reviewed in Tanzi, 2005) . However, a failure to understand the initiating events that drive AD pathogenesis limits the development of effective tools to reverse this disease.
Clinical observations suggest among the first AD symptoms is an impairment in learning (Buckner, 2004) . In support of Ab peptides driving this deficit, Ab is the earliest known biomarker in AD patients (Jack et al., 2013) . Further, genetic mutations resulting in Ab overproduction lead to AD (Selkoe, 2001) . Finally, Ab peptides isolated from AD patients trigger synapse loss, reduce synaptic plasticity, and compromise learning in rodents (Shankar et al., 2008) . While it has been assumed Ab acts by eliminating existing synapses, little work has validated this claim or explored whether Ab might compromise new synapse assembly. Given emergent synapses are essential for new memory acquisition (Hayashi-Takagi et al., 2015) , one might predict learning deficiencies in AD result from deficits in new synapse assembly.
Numerous features of brain circuits are altered during learning, including an increase in excitatory synapse size and changes in synaptic plasticity (Nabavi et al., 2014) , including long-term potentiation (LTP). Consistent with Ab compromising learning efficacy, neural circuits exposed to Ab peptides show reductions in spine size and LTP (Walsh et al., 2002; Shankar et al., 2007) . A critical intracellular mediator initiating synapse assembly, growth, and plasticity is calcium (Lohmann and Bonhoeffer, 2008; Yasuda et al., 2003) , yet how alterations in calcium impact learning remains poorly understood.
Calcium dysregulation is a hallmark feature of AD (Bezprozvanny and Mattson, 2008) . Elevated levels of serum calcium correlate with cognitive decline during aging and AD (Schram et al., 2007) . Calcium imaging studies in AD mouse models or following Ab exposure show populations of neurons that are aberrantly hyperactive or silent (Busche et al., 2012) . Several receptors bind Ab and contribute to aberrant calcium activity in neurons (reviewed in Jarosz- Griffiths et al., 2016 ), yet how these receptors function is unclear.
A central regulator restricting synapse assembly and plasticity is the Nogo receptor family (NgR1-3, also known as Rtn4r, Rtn4rl2, and Rtn4rl1, respectively; Mironova and Giger, 2013) . Blocking NgR signaling augments synaptic plasticity in numerous brain regions. Loss of the NgR family (NgR TKO ) increases excitatory synapse number in the hippocampus, triggered by new synapse assembly resulting from NgR loss on (A) Live imaging of hippocampal slices reveals ADDLs (150 nM) reduce dendritic spine density relative to controls (CON; 0.02% DMSO) by inhibiting new spine assembly. Top: representative images of CA1 pyramidal neurons (9 days in vitro; DIV) labeled with vGFP reveal (higher magnification below) a decrease in new (green < 48 hr old) and persistent spines (white > 48 hr old) following ADDL exposure but no effect on eliminated spines (lost within last 48 hr). Scale bars, 10 (top) and 1 mm (below).
(legend continued on next page)
dendrites (Wills et al., 2012) . NgR1 is known to bind Ab, yet NgR's role in Ab's synaptic pathologies remains unexamined (Park et al., 2006) . NgRs restrict synaptogenesis via the GTPase RhoA and its downstream effector Rho kinase (ROCK; Wills et al., 2012) . ROCK inhibits cytoskeletal assembly via phosphorylation of numerous cytoskeletal substrates (Schmandke et al., 2007) . While RhoA and ROCK are implicated in Ab's synaptic pathologies, the Ab receptors activating them and their cellular targets remain undefined. ROCK regulates numerous voltage-gated calcium channels (VGCCs; Iftinca et al., 2007) , suggesting ROCK might modulate calcium signaling to mediate its effects on synaptic development. T-type calcium channels (CaV3.1-3.3, also known as Cacna1g, Cacna1h, and Cacna1i, respectively) are expressed on pyramidal neurons and contribute to synaptic calcium signaling, making them compelling candidates for mediating NgR-ROCK-dependent synaptic biology (Magee et al., 1995; McKay et al., 2006) .
In this study, we sought to define the mechanism by which Ab compromises learning. We determined Ab inhibits new synapse assembly and identify the NgR family as mediating Ab's inhibition of synaptogenesis and synaptic plasticity. Imaging studies pinpoint Ab activates NgR-RhoA signaling on the dendritic shaft of hippocampal neurons, where it inhibits calcium signaling. Electrophysiology demonstrates T-type calcium channels are a target of Ab-NgR signaling, mediating Ab's inhibition of synapse development, plasticity, and calcium signaling. In vivo studies reveal Ab reduces spine number, T-type currents, and new learning via the NgR family. This study highlights that deficits in new synapse assembly may contribute to learning difficulties emerging early in AD progression, and identifies NgRs and T-type calcium channels as key mediators.
RESULTS

ADDLs Inhibit New Spine Assembly Dependent on NgR1
Neurons exposed to Ab peptides show reduced numbers of excitatory synapses (Shankar et al., 2007) ; however, whether synapse loss results from increased synapse elimination or decreased synapse addition has not been examined. To address this question, we tracked dendritic spine addition and elimination in live imaging studies of hippocampal slice cultures following neuronal exposure to oligomeric preparations of Ab peptides (ADDLs; Ab-derived diffusible ligands). CA1 pyramidal neurons were biolistically labeled with venus GFP (vGFP) and primary apical dendrites were imaged every 2 days over a 6-day period using confocal microscopy (Wills et al., 2012) . ADDLs were prepared as outlined in Figure S1 (Nicoll et al., 2013) . The concentration, size, and oligomeric status of Ab peptides were assessed by high-performance liquid chromatography (HPLC), size exclusion chromatography (SEC), and electron microscopy (EM), respectively ( Figure S1 ). We find $30% of our ADDL preparations run as oligomers at $500 kDa, equivalent to $100 Ab peptide monomers (Nicoll et al., 2013) .
Following exposure to ADDLs (150 nM), we observe a significant reduction in overall spine density in CA1 pyramidal neurons at both 48 and 96 hr (Figures 1A and 1B) . Quantification of spine addition (green numbers) and elimination (red numbers) reveals ADDLs inhibit spine addition at both time points relative to controls, while spine elimination rates remained unaffected ( Figures 1A and 1B) . In contrast, monomeric Ab (ABm) peptides or a DMSO control has no effect on spine density ( Figure S1E ). These findings demonstrate ADDLs specifically inhibit new spine addition to reduce synapse number.
Given NgRs are known to restrict new spine addition (Wills et al., 2012) , we considered whether NgRs mediate Ab's inhibition of synapse assembly. Following biolistic introduction of a validated short hairpin RNA interference (shRNAi) targeting NgR1 in hippocampal slices, we find, consistent with previous work (Wills et al., 2012) , that NgR1 loss increases spine density over a 48-hr period, an effect resulting from augmented spine addition ( Figures 1C and 1D ). Strikingly, neurons lacking NgR1 still show an increase in spine density and spine addition after ADDL exposure over a 48-hr period, comparable to shNgR1 neurons alone. Spine elimination is unaffected in all conditions. These findings reveal NgR1 is required for Ab's inhibition of new spine assembly.
NgRs and ROCK Mediate ADDL Inhibition of LTP NgR signaling restricts learning and new spine assembly triggered during this process (Zemmar et al., 2014) . To gain mechanistic insight into how NgRs function, we assessed LTP, a plasticity mechanism required for learning (Nabavi et al., 2014) . Given AD is an aging-associated disease, we carried out studies in 6-to 10-month-old mice, the age at which LTP deficits first emerge in several AD mouse models (Oddo et al., 2003) . In field excitatory postsynaptic current (fEPSC) recordings of CA1 pyramidal neurons following high-frequency stimulation of Schaffer collateral axons, we find animals lacking all three NgRs (NgR1 (B) Left: spine density quantification reveals ADDL exposure (red) reduces spine density at indicated times relative to CON (black). Quantification of spine addition (middle) and elimination (right) reveals ADDL exposure reduces spine addition at indicated times relative to control but has no effect on spine elimination. *p < 0.02 versus CON. Student's t test. n = 3 experiments. Data are means; error bars represent SEM.
(C) Representative high-magnification images of CA1 pyramidal neurons expressing shNgR1 and vGFP reveal at 48-hr time period that NgR1 loss rescues neurons from ADDL-mediated inhibition of spine addition (green) with no effect on spine elimination (red). (D) Left: quantification of mean spine density reveals ADDL-mediated reduction in spines (red) is reversed following shNgR1 expression (orange) relative to CON (black) at 48 hr. Quantification of spine addition (middle) and elimination (right) reveals NgR1 loss (orange) reverses ADDL-mediated inhibition of spine addition (red) but has no effect on spine elimination. *p < 0.05 versus CON. **p < 0.0001 versus ADDL. One-way ANOVA with Tukey's post hoc test. n = 3 experiments. Data are means; error bars represent SEM. See also Figure S1 and Table S1 . Figure S2 ) or paired-pulse ratio (PPR) was observed in NgR NNN animals, suggesting augmented LTP resulting from NgR family loss is likely due to some postsynaptic alteration. To address whether NgRs mediate Ab inhibition of synaptic plasticity (Walsh et al., 2002) , we assessed ADDL inhibition of LTP in our hippocampal slice preparations. Consistent with pre- Figure S2 and Table S1 .
vious work, we observe a decrease in LTP following ADDL exposure (150 nM) in control slices ( Figure 2B ). Strikingly, in NgR family knockouts (NgR NNN ), we find ADDL inhibition of LTP is reversed, reaching an fEPSC slope indistinguishable from NgR NNN animals alone. These observations demonstrate the NgR family is required for Ab's inhibition of synaptic plasticity.
To determine whether Ab functions via known intracellular mediators of NgR signaling (Wills et al., 2012) , we asked if ROCK is required for Ab's inhibition of LTP. We find preincubation of brain slices with a ROCK inhibitor, Y27632 (1 mM), reverses ADDL's inhibition of LTP (Figure 2C ), similar to NgR family loss. Interestingly, in control neurons we find ROCK inhibition (Y27632) blocks LTP ( Figure 2C ), in contrast to NgR family loss. These observations are consistent with previous work demonstrating ROCK is required for LTP (Rex et al., 2009 ). These findings suggest NgRs and ROCK have distinct roles in regulating LTP under physiological conditions, but under pathological conditions modeling AD, the NgR-ROCK signaling pathway is recruited to mediate Ab's synaptic pathologies.
Consistent with these findings, we observe ROCK inhibition (Y27632; 1 mM) reverses LTP deficits in an AD mouse model (3xTG-AD; Oddo et al., 2003) , where patient mutations have been engineered in presenilin, APP, and tau ( Figure 2D ). Overall excitability (input/output curves; Figure S2 ) and PPR are unaltered in 3xTG-AD mice, suggesting LTP deficit in these animals has a postsynaptic origin.
ADDLs Bind NgR1 on the Dendritic Shaft of Neurons Given our findings that NgRs mediate numerous effects of Ab, we considered whether NgRs might be receptors for ADDLs. Previous work demonstrated that NgR1 binds ABm 1-42 peptide (Park et al., 2006) . However, NgR1 binding to oligomeric Ab (ADDLs) has not been examined, nor has NgR2 or NgR3's affinity for ADDLs been investigated. To address these questions, biotin-tagged Ab 1-42 peptide oligomers (ADDLs) were prepared as described earlier ( Figure S1 ). The concentration and size of biotin-tagged ADDLs and ABm 1-42 were confirmed by HPLC, SEC, and EM.
When NgR family members are expressed in heterologous cells, we find biotin-tagged ADDLs bind NgR1 ( Figures 3A-3C ), but not NgR2 or NgR3. These observations suggest that, among NgR family members, only NgR1 binds ADDLs. A quantification of the size and intensity of Ab puncta demonstrates ADDLs bind more avidly to NgR1 than ABm.
To assess whether NgR1 functions as an Ab receptor during synapse development, ADDL binding studies were carried out on primary hippocampal neuron cultures following the expression of an shRNAi previously validated to eliminate NgR1 cell-surface expression (Wills et al., 2012) . shRNAi targeting of NgR1 resulted in a marked reduction in ADDL binding along GFP-positive dendritic shafts of neurons, both in terms of puncta density and intensity ( Figures 3D and 3E ). Further, ADDL binding was reduced at synaptic sites following NgR1 loss, highlighted by immunostaining with the postsynaptic protein PSD95. Consistent with these findings, ADDLs and NgR1 co-localize predominantly at asynaptic sites along the dendritic arbor of hippocampal neurons, as revealed by ADDLNgR1 immunostaining ( Figure 3G ). These experiments suggest NgR1 mediates Ab's inhibition of synapse assembly and plasticity by binding ADDLs at asynaptic sites along the dendritic arbor.
ADDLs Activate RhoA and Inhibit Calcium Signaling in the Dendritic Shaft To define the initiating site of Ab's synaptic pathologies mediated by NgR1, we developed an imaging approach to visualize Ab-NgR signaling live in neurons. Our current work suggested RhoA is a likely mediator of Ab-NgR signaling. We hypothesized visualizing RhoA activity in neurons following Ab exposure would identify where Ab-NgR signaling is initiated. To track RhoA activity, we introduced a RhoA FRET (Fö rster resonance energy transfer) sensor (RhoA2G; Fritz et al., 2013;  Figure S3A ) into hippocampal neurons. Our validation studies illustrate the RhoA2G sensor can resolve RhoA activity in hippocampal neurons cultures ( Figures S3A-S3G ). To assess sensor activity, regions of interest (ROIs; 5-10 mm boxes) were defined along the dendritic shaft, soma, spine, and axon. Photoacceptor bleaching studies demonstrate the fluorescence emissions from the RhoA sensor are FRET signals, since bleaching of the photoacceptor vGFP results in a rise in the donor fluorophore mTFP ( Figure S3E ), a defining feature of FRET (Nakamura et al., 2005) . Pharmacological modulators of RhoA (LPA [activator] or C3 [inhibitor]) alter RhoA2G sensor activity when perfused onto neurons (Figure S3F) , demonstrating we can detect acute perturbations in RhoA activity. Overexpression of a known RhoA GAP (GTPaseactivating protein; P50 GAP) or RhoA GEF (guanine exchange factor; DBL) alters baseline RhoA2G activity relative to control neurons (Pertz et al., 2006) , showing we can detect chronic changes in RhoA activity ( Figure S3G ).
To visualize calcium responses to ADDLs in neurons, we expressed a red-shifted genetically encoded calcium sensor (RCaMP; Akerboom et al., 2013;  Figure S3B ) along with RhoA2G into neurons, since Ab exposure increases intracellular calcium in neurons (Um et al., 2013) . Glutamate uncaging studies demonstrate RCaMP can resolve small calcium changes in the dendritic spine ( Figure S3H ). KCl perfusion onto neurons shows RCaMP has a robust dynamic range and detects changes in calcium in axons, dendrites, and spines ( Figure S3I ). Importantly, we can resolve RhoA2G (vGFP/ mTFP) and RCaMP (mRuby) sensor emissions simultaneously using spectral imaging and unmixing ( Figures S3C and S3D ), since simultaneous (457 and 561 nm) or individual (457 or 561 nm) excitation of RhoA2G and RCAMP sensors results in comparable measures of fluorophore emission. Lastly, we observe no detrimental effects on cell health, dendritic growth, or synapse density by coexpression of RhoA2G and RCaMP in neurons ( Figure 3A ; data not shown).
Following ADDL addition onto neurons expressing both RCaMP and RhoA2G sensors, we observe calcium and RhoA responses with distinct temporal and spatial characteristics. ADDLs elicit a short-lived calcium peak in both dendrites and spines . Following this acute response, we observe a long-lasting reduction in calcium (>15 min) that is specific to the dendritic shaft (Movie S1). Interestingly, coincident with the Ab-induced reduction in calcium in the dendritic shaft, we observe a long-lasting rise in RhoA activity. In contrast, ADDL exposure to dendritic spines results in a modest long-term increase in both RhoA and calcium ( Figures 4C and S4A ). ADDL exposure has no effect on calcium activity in axons but does result in a small rise in RhoA ( Figure S4E ). Controls, including DMSO alone, Ab 42-1 peptide, and Ab 1-42 monomer, do not alter calcium or RhoA sensors ( Figure S4G ). ADDL exposure not only reduces baseline calcium activity in dendrites, but also calcium transients associated with synaptic growth (Figure S4I ; Lohmann and Bonhoeffer, 2008) . These observations suggest Ab triggers distinct signaling events in the dendritic shaft, spines, and axons of hippocampal neurons.
To address whether Ab functions via NgR1 to modulate RhoA and calcium signaling, we imaged neurons where NgR1 had been targeted by shRNAi (Wills et al., 2012) . Following RNAi-mediated loss of NgR1, neurons exposed to ADDLs do not activate RhoA or inhibit calcium signaling in shaft ROIs (Figures 4D, S4C , and S4H). Consistent with this finding, dendritic calcium transients are also unaffected by ADDLs in NgR-minus neurons ( Figure S4I ). Further, in dendritic spines lacking NgR1, ADDLs no longer trigger RhoA and calcium activity ( Figure S4H ). Naturally secreted soluble Ab oligomers more closely resemble Ab peptides isolated from AD patients and inhibit synaptic plasticity at lower concentrations than synthetic Ab oligomers (Welzel et al., 2014) . We isolated soluble Ab peptides secreted from cultured cells expressing an AD-associated mutant (APP V717F ; 7PA2 cells), confirmed their oligomeric status by western blot analysis (data not shown), and exposed neurons to soluble oligomers. In cultured hippocampal neurons expressing RhoA2G and RCaMP sensors, soluble Ab oligomers (7PA2) activate RhoA and inhibit calcium signaling along the dendritic shaft, analogous to synthetic ADDLs ( Figure S4B ). Further, neurons lacking NgR1 (shNgR1) do not activate RhoA or inhibit calcium signaling following 7PA2 cell extract exposure ( Figure S4C ), demonstrating soluble Ab oligomers, like synthetic ADDLs, signal via NgR1. 7PA2 cell extracts also trigger an acute calcium rise in neurons independently of NgR1, similar to ADDLs. Note that control cell supernatant (Chinese hamster ovary; CHO) had no effect on RhoA or calcium activity ( Figure S4F ). Finally, 7PA2 cell extracts reduce dendritic spine density in hippocampal slice cultures dependent on NgR1 (shNgR1; Figure S4D ). These observations suggest NgR1, upon binding to Ab oligomers, either from cell-derived or synthetic sources, triggers a sustained activation of RhoA and inhibition of calcium signaling along the dendritic shaft of hippocampal neurons that results in a reduction in dendritic spines. In contrast, acute calcium responses to Ab in neurons are independent of NgR signaling.
NMDARs mediate aspects of Ab-dependent calcium signaling in neurons (Shankar et al., 2007; Arbel-Ornath et al., 2017) . We therefore investigated the role of NMDARs in Ab's modulation of RhoA and calcium activity in dendrites. Following NMDAR inhibition (AP5, 1 mM), acute calcium responses to ADDLs in the dendritic shaft of neurons are lost, but long-term activation of RhoA and inhibition of calcium signaling are preserved ( Figure S4E ). These findings suggest Ab acts via NMDARs to acutely increase calcium while independently signaling through NgR to modulate RhoA and calcium activity over a longer time period.
T-Type Channels Contribute to Synapse Development, Plasticity, and Calcium Signaling in Dendrites To determine the potential calcium regulatory target of NgR-Ab signaling in the dendritic shaft, we exposed neurons expressing RCaMP with various pharmacological blockers. Numerous VGCCs are highly expressed in the dendritic shaft (Yasuda et al., 2003; McKay et al., 2006) . We examined whether blockers of VGCCs alter RCaMP sensor levels in dendrites. Among pharmacological blockers of VGCCs, NNC and TTA-P2, inhibitors of T-type calcium channels, elicited the largest reductions in baseline calcium in dendrites (Figures 5E and S5E) . None of the VGCC blockers had deleterious effect on cell health or dendritic spines over this imaging period.
T-type channels (CaV3.1, CaV3.2, and CaV3.3) are highly expressed on dendrites of hippocampal pyramidal neurons and mediate synaptic calcium signaling (McKay et al., 2006; Magee et al., 1995) . Given our findings, we considered whether T-type channels contribute to synapse development. To determine T-type channel expression during synapse development, cultured hippocampal neurons were immunostained with antibodies for individual channels. Antibody specificity was confirmed by immunostaining neurons expressing shRNAis targeting individual channels ( Figure S5 ). Antibody staining is reduced on neurons expressing shRNAis targeting each T-type channel, demonstrating the efficacy of both shRNAis and antibodies. We find CaV3.1, CaV3.2, and CaV3.3 are expressed along the dendritic shaft of hippocampal neurons ( Figure 5A ). Further, some staining overlaps with the postsynaptic protein PSD95, suggesting T-type channels are present at synapses.
To address whether T-type channels contribute to synaptic development, shRNAis targeting individual channels were introduced into hippocampal slice or dissociated neuron cultures along with vGFP. RNAi targeting of CaV3.1 or CaV3.3 reduced dendritic spine density in hippocampal slice cultures relative to an shRNAi control ( Figure 5B ). Consistent with these findings, RNAi targeting of CaV3.1 or CaV3.3 in dissociated hippocampal neurons reduced the density of protein markers of excitatory synapses (PSD95 and Synapsin 1) relative to controls (shCON) ( Figure S5B ). Importantly, these shRNAis were functionally validated (Park et al., 2010;  Figure S5B ). Expression of an RNAi-resistant CaV3.3 (WTVCaV3.3 (R)) rescued synapse density deficit resulting from RNAi targeting of this channel Figure S4 and Table S1 . (legend continued on next page) (shCaV3.3#1), demonstrating the specificity of this RNAi for CaV3.3. A second RNAi targeting CaV3.3 (shCaV3.3#2) also reduced synapse density relative to controls in these neuron cultures, corroborating our findings that CaV3.3 is necessary for synaptic development ( Figure S5B ). Mini excitatory postsynaptic current (mEPSC) recordings in dissociated neurons lacking CaV3.1 alone or CaV3.1 and CaV3.3 in combination reveal a reduced mEPSC frequency relative to controls (Figures 5C and S5C) . In contrast, shRNAi targeting of CaV3.1 and CaV3.3 has no effect on mEPSC amplitude ( Figure S5D ). These findings suggest CaV3.1 and CaV3.3 contribute to the establishment of functional excitatory synapses during development, but not their strengthening once formed. In contrast, CaV3.2 appears not to contribute to excitatory synapse development, since neither of the two shRNAis targeting CaV3.2 alter spine density or markers of excitatory synapses in our studies (data not shown). Importantly, RNAi targeting of T-type channels (shCaV3.1-3.3) eliminates NNC and TTA-P2's inhibition of calcium signaling in dendrites ( Figure S5E ), demonstrating the specificity of these blockers for T-type channels.
We hypothesized that if T-type channels participate in Ab signaling, they should contribute to plasticity regulated by Ab. Consistent with this hypothesis, we find the T-type channel blocker NNC inhibits LTP in acute hippocampal slices (Figure 5C ). Note that NNC shows no pathological effects on dendritic spines in hippocampal slice cultures (data not shown). In contrast, nimodipine, an L-type channel blocker, has no effect on LTP. In total, these studies identify T-type channels as mediators of dendritic calcium signaling, synapse assembly, and synaptic plasticity.
To address whether intracellular mediators of Ab-NgR signaling alter calcium in dendrites, we exposed RCaMP-expressing neurons to the ROCK inhibitor Y27632 ( Figure 5D ). Interestingly, we observe a marked rise in RCaMP activity in the dendritic shaft of neurons following ROCK inhibition, suggesting ROCK functions to restrict calcium signaling in the shaft. Note that Y27632 has no deleterious effects on neuron health (Wills et al., 2012) .
ADDLs Inhibit T-Type Channels Mediating LTP Loss
Given previous work demonstrates RhoA signaling can inhibit T-type channels (Iftinca et al., 2007) , we considered whether Ab-NgR signaling inhibits synapse assembly and plasticity by blocking T-type channels. To address this question, we recorded whole-cell T-type currents from cultured hippocampal neurons before and after ADDL exposure. T-type currents were isolated by a stepwise voltage regime ( Figures S6 and 6A) . Following ADDL exposure, we observe a marked reduction in peak amplitudes of T-type currents ( Figures 6A and 6C) . Further, ADDL exposure results in a leftward shift in activation and inactivation curves of T-type currents (G/G max and I/I max ), suggesting Ab alters activation and inactivation properties of T-type channels ( Figures S6B and S6C ). ADDL's inhibition of T-type currents was comparable to T-type channel blockers NNC and TTA-P2 ( Figures 6B and 6C) . Importantly, only low-voltage activated (LVA) currents are inhibited by ADDLs, not high-voltage activated (HVA) currents. Further recordings under control conditions reveal no current rundown over the recording period (Figure 6B) . Finally, blocking all HVA calcium channels (Agatoxin, Conotoxin, and Nimodipine) had no effect on ADDL's inhibition of LVA currents ( Figure S6D ), suggesting that, among VGCCs, ADDLs exclusively inhibit T-type channels.
To determine which T-type channel(s) Ab signaling inhibits, we introduced shRNAis targeting T-type channel into neurons and exposed neurons to ADDLs. Given CaV3.1 and CaV3.3 contribute to synapse development, we combined shRNAis targeting these channels. An shRNAi targeting CaV3.2 (shCaV3.2) served as a control, since CaV3.2 does not contribute to synapse development. We find ADDLs no longer block T-type currents in neurons lacking CaV3.1 and CaV3.3, demonstrating these channels are targets of ADDL-mediated inhibition (Figure 6C ). In contrast, T-type currents in shCaV3.2-expressing neurons were inhibited comparably to controls, demonstrating CaV3.2 is not a target of Ab signaling. Recordings from shCaV3.1-and shCaV3.3-expressing neurons also reveal a significant reduction in baseline currents ( Figure S6C ). In contrast, baseline currents in neurons expressing shCaV3.2 are unaltered. These findings demonstrate CaV3.1 and CaV3.3 channels contribute to endogenous T-type currents in hippocampal neurons during synaptic development, while CaV3.2 has no role. We hypothesize that residual current in neurons lacking CaV3.1 and CaV3.3 are from high-voltage calcium channels ( Figures 6B and S6D) . Finally, neither NNC nor TTAP2 inhibit LV currents in neurons lacking all T-type channels (shCaV3.1-3.3), demonstrating the fidelity of our recordings and specificity of these blockers ( Figure S6F ).
To determine whether T-type channels contribute to ADDL's synaptic pathologies, we examined whether blocking T-type channels (NNC) in combination with ADDLs alters the inhibition of LTP we observed with either treatment alone. We find combining NNC and ADDL has no greater inhibition of LTP than either ADDL or NNC alone ( Figure 6D ), consistent with Ab inhibiting T-type channels to block synaptic plasticity.
To determine whether ADDL inhibition of T-type channels blocks calcium signaling in neurons, sensor-expressing neurons lacking CaV3.1 and CaV3.3 (shCaV3.1-shCaV3.3) were exposed to ADDLs ( Figure 6E ). In neurons lacking CaV3.1and CaV3.3, ADDL exposure still elicits an acute peak in calcium activity Figure S5 and Table S1 . and long-term activation of RhoA, but the sustained inhibition of calcium activity observed in dendrites of control neurons is lost. Acute calcium responses to ADDLs are also preserved in the dendritic spines of neurons lacking CaV3.1 and CaV3.3 (Figure S6E) , while long-term activation of RCaMP and RhoA normally seen in control neurons is lost, suggesting T-type channels also contribute to Ab signaling in spines. Neurons expressing shCaV3.2 show comparable RhoA and calcium responses to ADDLs as controls ( Figure S6F ). These observations suggest Ab signaling inhibits CaV3.1 and CaV3.3 in the dendritic shaft, compromising calcium influx through these channels.
NgR Signaling Mediates ADDL Inhibition of T-Type Channels, Calcium Signaling, and LTP Loss To address whether Ab inhibits T-type channels via NgR-Rho signaling, we asked if activating RhoA in neurons is sufficient to inhibit T-type channels. We find LPA, a receptor agonist that activates RhoA (Wills et al., 2012;  Figure S4F ), inhibits T-type currents with a magnitude comparable to that of ADDLs ( Figures  7A and 7C ). In contrast, ROCK inhibition (Y27632, 1 mM) reverses ADDL's block of T-type channel currents ( Figure 7B ), demonstrating Ab signaling acts via ROCK to inhibit T-type channels. RNAi-mediated knockdown of NgR1 also reverses ADDL's CaV3.1 isoforms were coexpressed with GFP in hippocamapal slice cultures, exposed to ADDLs (150 nM), fixed, and stained. CA1 pyramidal neurons were imaged by confocal microscopy as illustrated. Arrowheads indicate mature dendritic spines. Scale bar, 1 mm. Right: quantification of dendritic spine density in indicated conditions below. Mean spine density expressed relative to control condition (vGFP alone). Error bars represent SEM. n = 3 experiments. *p < 0.05 versus CON. **p < 0.005 versus ADDL. One-way ANOVA with Dunnet's post hoc test. See also Figure S7 and Table S1 . inhibition of T-type currents ( Figure 7C ), demonstrating NgR1 is the Ab receptor activating ROCK signaling.
To determine whether ROCK mediates Ab's inhibition of dendritic calcium signaling, we incubated sensor-expressing neurons with the ROCK inhibitor Y27632 and exposed these neurons to ADDLs ( Figure 7D ). Following ROCK inhibition, ADDL-mediated inhibition of dendritic calcium signaling in neurons is lost. However, following a washout of Y27632, ADDL's inhibition of dendritic calcium signaling is restored. Complimentary non-washout sensor imaging studies confirm ADDL inhibition of dendritic calcium signaling is lost following ROCK inhibition (Figure S7A ). These studies demonstrate ROCK activity mediates Ab's inhibition of T-type channel calcium influx in the dendritic shaft of neurons.
To determine if T-type channels contribute to Ab-NgR-mediated inhibition of LTP, we assessed Ab's inhibition of LTP following ROCK inhibition (Y27632) or loss of the NgR family (NgR NNN ) in acute hippocampal slices. We find the T-type channel blocker NNC reverses the capacity of ROCK inhibition (Y27632) or NgR loss (NgR NNN ) to rescue neurons from ADDL-mediated LTP reduction ( Figure 7E ). These findings suggest both NgRs and ROCK function via T-type channels to mediate Ab's LTP inhibitions. Interestingly, NNC alone reverses the augmented LTP in NgR family knockouts (NgR NNN ), suggesting T-type channels are also required for NgR's inhibition of LTP under normal physiological conditions. ADDL Inhibits T-Type Channels by ROCK Phosphorylation of CaV3.1 Our work demonstrates ROCK activity is required for Ab-mediated inhibition of T-type currents, suggesting ROCK might directly phosphorylate T-type channels. Previous work (Iftinca et al., 2007) revealed ROCK phosphorylates CaV3.1 at two consensus phosphorylation sites (M1 and M2). To determine whether Ab inhibits T-type channels via ROCK-mediated phosphorylation of CaV3.1, we overexpressed in neurons a CaV3.1 M1+M2 mutant incapable of being phosphorylated by ROCK (Iftinca et al., 2007) . Relative to WTCaV3.1, we observe a marked rescue of Ab's inhibition of T-type currents in neurons expressing CaV3.1 M1+M2 ( Figure 7F ), despite comparable expression of these two CaV3.1 constructs ( Figure S7B ). These observations suggest the CaV3.1 M1+M2 mutant is at least partly resistant to Ab signaling-mediated inhibition, consistent with Ab triggering ROCK phosphorylation of CaV3.1 at M1 and M2 sites. We hypothesize residual T-type currents inhibited by Ab in neurons expressing CaV3.1 M1+M2 are from endogenously expressed T-type channels. Consistent with this hypothesis, overexpression of CaV3.1 M1+M2 did not significantly increase baseline T-type current amplitude relative to control neurons ( Figure S7C) .
To address the significance of ROCK phosphorylation of CaV3.1 in Ab-mediated synaptic pathologies, hippocampal slice cultures overexpressing CaV3.1 M1+M2 were exposed to ADDLs and dendritic spines analyzed. We find CaV3.1 M1+M2 overexpression protects CA1 pyramidal neurons from ADDLmediated reductions in spine number ( Figure 7G ). Interestingly, expressing the CaV3.1 M1+M2 mutant alone in neurons increases spine density relative to controls, suggesting ROCK phosphorylation of CaV3.1 also restricts synapse assembly during development.
To address whether ROCK phosphorylation of CaV3.1 mediates ADDL's inhibition of calcium signaling in dendrites, CaV3.1 M1+M2 , along with RhoA and RCaMP sensors, was coexpressed in neurons that were exposed to ADDLs ( Figure S7D ). In contrast to control neurons (CaV3.1 WT ), ADDLs do not inhibit calcium signaling in CaV3.1 M1+M2 mutant neurons. These observations suggest ROCK phosphorylation of CaV3.1 is essential for Ab's inhibition of calcium signaling in dendrites.
ADDLs Block Learning via NgR-Mediated Inhibition of Spine Assembly and T-Type Channels
An important measure of Ab pathology is its impact on learning. To determine the role of NgRs in Ab-mediated inhibition of learning, we introduced ADDLs ($10 pmols) via a single intracerebroventricular (ICV) injection into the mouse brain ( Figures 8A  and S8A ) and examined its impact on novel object recognition (NOR) learning. Consistent with previous work (Figueiredo et al., 2013) , ADDLs block NOR learning 7 days after ICV injection in comparison to control (DMSO)-injected animals ( Figure 8B ). In contrast, NgR family knockouts (NgR NNN ) are unaffected by
ADDLs, showing normal NOR behavior (right panel). Note that none of the ICV-injected animals show deficits in movement
(open field analysis; Figure S8C ). These findings suggest NgRs mediate Ab's inhibition of learning. To address whether excitatory synapse loss correlates with Ab-dependent learning deficits, we examined dendritic spines in ADDL-injected animals expressing GFP in pyramidal neurons in the hippocampus (Thy1-GFPm; Feng et al., 2000) . Eight days post-injection, we find a significant reduction in mature dendritic spines on CA1 pyramidal neurons in ADDL-injected animals relative to controls ( Figures 8C and S8D) . Strikingly, ADDL injections have no effect on spines in animals lacking the NgR family (NgR NNN ), demonstrating NgRs mediate Ab's spine deficits in vivo.
To determine whether NgR-mediated inhibition of T-type channels is associated with Ab learning deficits, we examined T-type channel currents in ADDL-injected animals. Note that the T-type channel blocker NNC inhibits LV currents in our acute hippocampal slice recording, demonstrating the fidelity of our recordings ( Figure S8E ). Recordings from ADDL-injected animals reveal a significant reduction in T-type currents relative to DMSO controls (left panel, Figures 8D and S8F ). In contrast, ADDL injections have no effect on T-type currents in NgR NNN animals (right panel, Figure 8D ), demonstrating NgRs are required for ADDL-mediated inhibition of T-type currents in vivo.
DISCUSSION
In this study, we sought to visualize how neuronal exposure to Ab oligomers (ADDLs) affects synapse assembly. While numerous studies have documented Ab's capacity to reduce dendritic spine density, it has been largely assumed this is driven by spine elimination. We find neuron exposure to ADDLs specifically reduces new spine assembly ( Figures 1A and 1B) . Recent in vivo spine imaging studies of two AD mouse models reveal specific deficits in new spine assembly consistent with our work (Zou , 2015) . Given new spine assembly is required for learning (Hayashi-Takagi et al., 2015) , we propose deficits in spine assembly following Ab exposure may be integral to impaired learning early in AD pathology. We sought to gain insight into how Ab compromises new spine assembly. We identify NgR1 as a receptor mediating Ab's inhibition of spine addition. Given new synapses are integral to learning, we examined the synaptic potentiation underlying this process, LTP (Nabavi et al., 2014) . We find the NgR family (NgR1-3) restricts LTP both under physiological conditions and a pathological condition modeling AD, exposure to ADDLs. While binding studies suggest that, among NgR family members, ADDLs only bind to NgR1, we find the NgR family is required for ADDL-mediated LTP inhibition. These findings are consistent with NgR's shared function in restricting synapse assembly during development (Wills et al., 2012) . While NgR2 and NgR3 are unable to bind ADDLs, we hypothesize they recruit coreceptors or ligands requisite for mediating NgRs synaptic functions. Numerous NgR2 and NgR3 coreceptors and ligands have been implicated in AD (Mironova and Giger, 2013) , suggesting the NgR family may convey multiple signals in mediating AD pathology.
NgRs are recognized as important inhibitors of nervous system plasticity (Mironova and Giger, 2013) . We find the NgR family inhibits LTP in adulthood, expanding the catalog of its known functions. We also uncovered that Ab peptides, agents believed to drive synaptic pathology in AD, act via NgRs to compromise synaptic function. Our work demonstrates that NgR1 associates with ADDLs along the dendritic shaft of neurons. Previous work implicated NgRs (NgR1-3) in AD pathology by binding APP and regulating its proteolysis (Park et al., 2006; Zhou et al., 2011) . Interestingly, in the case of NgR2, binding to APP is independent of the Ab peptide, highlighting that NgR binding to Ab and APP may fulfill distinct functions. Administration of an NgR1 peptide was previously shown to rescue learning deficits in an AD mouse model, an effect attributed to reducing Ab peptide production (Park et al., 2006) . Our work highlights the possibility that the beneficial effects of this NgR peptide might be the result of a direct block of Ab-NgR signaling, reversing Ab's inhibition of new synapse assembly. What distinguishes NgRs from a growing list of Ab receptors (Jarosz-Griffiths et al., 2016) is that NgRs function under non-pathological conditions to restrict new synapse assembly, synaptic plasticity, and learning, suggesting these receptors are integral to the synaptic biology gone awry in AD.
In this study, we identify RhoA and ROCK as key intracellular mediators of Ab-NgR synaptic pathologies. Ab signaling is known to regulate RhoA and ROCK protein stability in neurons, altering synapse number as a result (Pozueta et al., 2013) . However, how Ab-mediated RhoA activation impacted synaptogenesis was unclear. We provide evidence that RhoA and ROCK are activated by Ab-NgR signaling on dendrites to inhibit new synapse assembly. Interestingly, under physiological conditions, ROCK is required for LTP-induced synaptic plasticity, in contrast to NgRs. This is consistent with previous work demonstrating RhoA and ROCK are required for LTP-induced spine growth . We attribute a role for RhoA in mediating Ab signaling in the dendritic shaft. We speculate the Ab-RhoAmediated block in new synapse assembly on the dendritic shaft may contribute to LTP loss. LTP stimulation is known to induce new spine growth that correlates with LTP induction (Engert and Bonhoeffer, 1999) ; however, the functional impact of new spine growth on LTP has not been assessed. RhoA is known to activate ROCK, which in turn phosphorylates numerous cytoskeletal regulators (Schmandke et al., 2007) . Our study reveals RhoA-ROCK signaling has an unappreciated function inhibiting calcium signaling in neurons. Sensor imaging analysis reveals ADDLs activate RhoA via NgR1 specifically in the dendritic shaft of neurons. Further, only ADDLs, not ABm, are capable of triggering RhoA activation or altering spine density. Given ABm binds NgR1, we presume its inability to activate RhoA in neurons is because of ABm's reduced affinity for NgR1 or a coreceptor relative to ADDLs. Strikingly, following neuronal exposure to ADDLs, calcium signaling is specifically inhibited along the dendritic shaft, correlating with a rise in RhoA activity. In contrast, in spines, ADDLs activate RhoA and calcium signaling. We speculate RhoA signaling may target distinct calcium regulatory substrates in dendrites, spines, and axons.
Calcium dysregulation is a hallmark feature of pathology in AD and models of the disease (Bezprozvanny and Mattson, 2008) . Numerous calcium modulators have been implicated in AD pathology, but a clear understanding of how calcium dysregulation is initiated in the disease is lacking. We sought to track the initiating events driving calcium dysregulation and define its cellular mediators. We find Ab exposure drives an acute rise in calcium that is initiated in spines and dependent on NMDARs. These observations are consistent with in vivo studies demonstrating ADDLs trigger calcium overload in neurons dependent on NMDARs (Arbel-Ornath et al., 2017) . Over a period of days, NMDAR-dependent calcium influx is reduced following neuronal exposure to ADDLs, leading to synaptic depression (Shankar et al., 2007) . Our study illustrates there are alterations in calcium signaling independent of NMDARs, occurring over an intermediate period and resulting in reduced levels of calcium specifically in the dendritic shaft of neurons. Interestingly, this loss of calcium in the shaft is coincident with a rise in RhoA activity and is dependent on NgR1, suggesting this signaling initiates Ab-NgR synaptic biology. Given new spines form along the dendritic shaft, we propose Ab-NgR-mediated inhibition of calcium signaling compromises new synapse assembly.
T-type calcium channels are important calcium regulators in the dendritic shaft of pyramidal neurons in the hippocampus (McKay et al., 2006) . T-type channel expression is downregulated in the brain during aging and AD (Rice et al., 2014) , suggesting reduced function of these channels may be key in driving calcium dysfunction in AD. Further, chronic inhibition of T-type channels increases Ab peptide levels, suggesting T-type channel activity is linked with Ab production. Our work reveals that T-type channels are a target of Ab-NgR signaling, regulating Ab's inhibition of spine development, synaptic plasticity, and learning. Electrophysiological recordings of T-type currents demonstrate that Ab signals via NgR and ROCK to inhibit CaV3.1 and CaV3.3. This inhibition is mediated via ROCK phosphorylation of consensus sites on these channels that, when mutated, render it insensitive to Ab inhibition. Further, neurons expressing this CaV3.1 M1,M2 mutant are resistant to Ab-mediated inhibition of synapse development and the dendritic calcium loss that we propose drives pathology. The therapeutic potential of targeting T-type channels is highlighted by the identification of a drug, STK101 (ZSET1446), which enhances LTP (Moriguchi et al., 2012) , reverses learning deficits in an AD mouse model (Yamaguchi et al., 2006) , and is a T-type channel agonist (Yamamoto et al., 2013) . STK101 has shown promising results in numerous clinical trials aimed at treating AD (Gauthier et al., 2015) . This study illustrates the importance of tracking initiating events driving synaptic pathology in AD. Our live imaging studies reveal Ab specifically compromises new spine assembly. Sensor imaging demonstrates Ab signaling on the dendritic shaft drives this pathology. Electrophysiology pinpoints T-type channels as the target of Ab signaling. Finally, animal behavior studies demonstrate the relevance of NgR signaling in Ab-mediated learning deficits. Given the array of pathologies associated with Ab, use of such imaging-based approaches may have broader application in defining different phases of the disease state.
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Requests for NgR1
;NgR3 À/À mice require letters of permission from the MMRC (NgR1; Rtn4r tm1Matl ) and Lexicon Genetics (NgR2; Rtn4rl2 tm1Lex and NgR3; Rtn4rl1 Gt(OST188035)Lex ) since NgR NNN animals were generated by breeding of these animals.
EXPERIMENTAL MODEL AND SUBJECT DETAILS Sex and Age/ Developmental Stage of Experimental Models
In LTP studies 6-10 month old animals of both sexes were used in all analyses. In in vivo studies following ICV injections of Abeta peptides, including Novel Object Recognition (NOR), analysis of dendritic spines and acute slice recordings of T-type currents only male mice from 8-12 weeks of age were used, since initial NOR studies in WT female mice (data not shown) revealed deficits in performance relative to male litter mates. Note, previous NOR studies following ICV injections of Abeta peptides also exclusively analyzed male mice (Figueiredo et al., 2013) .
In vitro studies of dendritic spines (live and fixed imaging) were carried out in cultured hippocampal slices isolated from P6 Long-Evans rat pups of either sex at the indicated days in cultures.
In vitro studies of sensors, mEPSCs, IHC staining for synaptic proteins and T-type channel recordings were carried in dissociated neurons cultures from hippocampi dissected from E18 rat embryos of undefined sex from 3-5 month old Long-Evans pregnant females.
Species/strain of experimental models NgR1 À/À ; NgR2 À/À ; NgR3 À/À (NgR NNN ) mice were described previously (Wills et al., 2012) . The NgR1 À/À mice were provided by Marc
Tessier-Lavigne (Zheng et al., 2005) . The NgR2 À/À and NgR3 À/À mice were obtained from Lexicon Genetics. NgR animals were generated by breeding NgR NNN and NgR HHH mice. The Thy1-GFPm line (Feng et al., 2000) was breed with all NgR animals and the NgR colony is maintained on a mixed background. Animals were genotyped using a PCR-based strategy (Wills et al., 2012) . Primers are available upon request. All knockout strains were validated by western blot and/or RT-PCR (Wills et al., 2012) . 3xTG-AD mice (Oddo et al., 2003) were acquired from Jackson labs and genotyped based on a PCR approach suggested by the vendor. Long-Evans female rats (either pregnant or with newborn litters) were purchased from Charles River and housed prior to use. The use of these animals was approved by the Institutional Animal Care and Use Committee (IACUC) at University of Pittsburgh.
Husbandry and Housing Conditions
Mice were ear-tagged and genotyped by tail snipping at P15, weened at P25 and housed in cages with littermates of the same sex under conditions approved by IACUC. Bully mice or males previously exposed to females were housed in isolation, consistent with IACUC standards. During NOR analysis, ICV injected animals in their home cage were acclimated to a new room prior to Open Field studies and NOR analysis. Figure S1 were analyzed by HPLC and SEC. For size exclusion chromatography analysis, 50 mL of 100mM preps of peptide were injected onto a Superdex75 5/150 GL (GE) size exclusion column on an Agilent 1200 isocratic HPLC system with a flow rate of 0.25 mL/min. Ab peptides were momomerized by incubation in 6M guanidinium chloride. Sample retention volume was measured at 215nm and the relative retention size was compared to standards of known molecular weight. Ab peptide concentration was determined by reverse phase HPLC chromatography. For EM, 5 mL aliquots of different Ab samples were placed on fresh glow discharged carbon-coated grids (Electron Microscopy Sciences, Hatfield), adsorbed for 2 minutes and the excess liquid removed. Following a wash with MilliQ water, the sample was stained with uranyl acetate (1% W/V) for 45 s, and washed again. Samples were imaged using a Tecnai T12 microscope (FEI Company, Hillsboro, OR) operating at 120kV at a magnification of 30,000x. Images were acquired with an Ultrascan 1000 CCD camera with a post-column magnification of 1.4x. Soluble Ab peptides were isolated from Chinese hamster ovary cells (CHO) stably expressing APP751 with the Val717Phe familial Alzheimer's disease mutation (7PA2 cells; Podlisny et al., 1995) . Conditioned media from confluent 7PA2 cells or CHO control cells cultured in plain DMEM for 16hrs was concentrated $10X (Welzel et al., 2014 ; YM-3 Amicon filters) before being used on neurons.
For live imaging studies in slice culture synthetic Ab peptides were used at a concentration of 500 nM (monomer equivalent) and 7PA2 extracts used at 1-2 $nM (Welzel et al., 2014) . To study the short-term ($30 minutes) effects of Ab peptides in sensor imaging studies, Ab peptides were used at a concentration of 1 mM. Based on our SEC analysis and previous work (Nicoll et al., 2013; Lauré n et al., 2009) we estimate the concentration of ADDLs used in this study are significantly less than one half the monomer equivalent (150 nM).
Hippocampal Slice Culture Preparation
Hippocampal slices were prepared from P5-7 Long-Evans rat pups as previously described (Wills et al., 2012) . Slices were cultured under sterile conditions on nylon inserts (0.4 mm pore size, Millicell) in 6-well dishes containing 0.75ml of antibiotic-free media (MEM) supplemented with 20% horse serum. Slice cultures were transfected using a Helios Gene Gun (Biorad) at 4 DIV. For live imaging studies cultures were supplemented with Fungizone (0.25 mg/mL) and penicillin/streptomycin (1 U/mL and 1 mg/mL, respectively).
Primary Neuron and Heterologous Cell Cultures
Hippocampal neurons were dissected from E18 Long-Evans rat embryos as previously described (Wills et al., 2012) . Dissociated hippocamapl neurons (1x10 5 cells per well) were plated on acid washed 12mm coverslips coated overnight with poly-D-lysine (HMW 20 mg/ml) and Laminin (3.4 mg/ml). Neurons were cultured in Neurobasal media (Invitrogen) supplimented with 2% B27 (Invitrogen), penicillin and streptomycin (100 U/mL and 100 mg/mL, respectively), and 2 mM glutamine. Two fifths of the media was replaced in each well every 4 days. At 9 DIV, neurons were transfected using the Lipofection method (Invitrogen: Lipofectamine 2000) . Neurons were trasfected with a total of 1 mg/well of DNA, including 250 ng CMV-vGFP, other plasmids of interest and PCS2 filler DNA.
HEK293T cells were plated (1x10 4 cells per well) on acid washed 12mm coverslips coated overnight with poly-D-lysine (HMW 20 mg/ml) cultured for 2hrs in DMEM supplimented with 10% fetal bovine serum, penicillin and streptomycin (100 U/mL and 100 mg/mL, respectively), and 2 mM glutamine and transfected using the Lipofection method (Invitrogen). A pDisplay NgR plasmid (750 ng) or PCS2 control DNA (750ngs) was trasfected along with cmv-vGFP (250ng) and cells were analyzed for Abeta binding 40hrs later as outlined earlier.
Chinese hamster ovary (CHO) cells expressing APP751 with the Val717Phe familial Alzheimer's disease mutation (7PA2 cells; Podlisny et al., 1995) or controls were grown in 10 cm plates in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, 100 units/mL penicillin, 100 mg/mL streptomycin, 2 mM L-glutamine and, in the case of 7PA2 cells, G418 (200 mg/mL) to select for cells expressing APP751. Cells were allowed to reach $90% confluence before being washed and cultured in unsupplemented DMEM for 16 hr before isolating soluble Ab peptides.
Ab Peptides Binding Studies
For Ab staining studies Biotin-LC-Ab (1-42) was added to heterolous cells tranfected with NgR receptors or 14DIV hippocamapal neurons, cultured for 1 hr at 37 C, washed and fixed as above. For Ab-NgR1 colocalization Biotin-LC-Ab (1-42) and an anti-NgR1 antibody ((1ug/ ml) goat; R&D systems) were coincubated with 14DIV hippocamapal neurons, cultured for 1 hr at 37 C, washed and fixed as above. A streptavidin-conjugated Alexa-555 secondary antibody (1:400; Invitrogen) was used to detect Biotin-LC-Ab while an anti-Rat Alexa-674 antibody was used to detect the NgR1 antibody.
Immunohistochemistry and Immunocytochemistry
Antibodies were diluted in a GDB buffer (0.1% gelatin; 0.3%TX-100; 15mM Phosphate Buffer (pH 7.4); 250mM NaCl). Alexa 488, 555 and 647 (1:400 [Invitrogen]) secondary antibodies were used to visualize primary antibodies.
For immunocytochemistry, primary neurons cultured on coverslips were fixed for 8 minutes in a freshly prepared paraformaldehyde (4%) sucrose (4%) PBS (pH7.4) solution, washed and incubated with the indicated antibodies overnight at 4 C, and stained with secondary antibodies at RT for 2hrs. Coverslips were mounted on glass slides using Fluormount-G (Southern Biotech) and imaged using a Nikon A1R laser scanning confocal.
Fixation of slice cultures was performed directly on the nylon culture membrane at 11DIV in 2.5% paraformaldehyde and 4% sucrose and processed for immunohistochemistry directly on mesh cutouts. Slices were 1 st incubated in a blocking buffer overnight (10% Goat Serum, 0.25% Triton X-100 in PBS (pH 7.4)), immunostained with anti-GFP (1:800; Aves lab).
For in vivo analysis of dendritic spines NgR animals coexpressing Thy1-GFPm (Feng et al., 2000) were perfused transcardially with fresh 4% paraformaldehyde in PBS (pH 7.4), brains were dissected out, post-fixed for 1 hour and washed overnight in PBS before vibratome sectioning (100 mm). Sections in net wells were immunostained with an anti-GFP antibody (1:800; Aves lab) and processed identically as slices cultures above.
Spine and Sensor Imaging As previously described (Wills et al., 2012) , for live imaging studies of spine assembly hippocampal slices on mesh inserts were transferred to 35 mm dishes filled with a HEPES-based ACSF. CA1 Positions and imaging locales of GFP-positive pyramidal neurons were carefully documented and regions of interest (secondary apical dendrites) were imaged using a 60x water-dipping objective (NA 1.0). Spines were designated based on previously defined criteria , encompassing thin, stubby and mushroom spines (0.5 mm % (spine length) L % 2.5 mm; (spine width) W h R 0.5 mm). All samples were blinded before imaging and only unblinded after dendritic spine analysis was complete.
For analysis of dendritic spines, fixed and immunostained vibratome sections from ICV injected animals were blinded for genotype and condition, then secondary proximal apical regions of CA1 pyramidal neurons from the left hippocampus (side proximal to ICV injections) were imaged by confocal microscopy (Nikon A1R at 2x zoom) using a 60x oil objective (NA 1.4). Z stacks (0.3 -0.5 mm) were used to encompass as much of the dendritic arbor as possible. Images were subsequently deconvolved to get rid of out of focus light (Nikon Elements) and analyzed to define spine types and features (length, width and volume) using Imaris software (Bitplane).
For analysis of Biotin-LC-Ab staining of heterologous cells transfected with NgR receptors or 14DIV hippocampal neurons, fixed and stained cells/neurons were imaged using a Nikon A1R confocal microscope. Transfected heterologous cells (GFP + and NgR + ) or neurons (GFP + ) were imaged at 60x in z stacks of 0.5 mm slices (4-6 per cell/neuron). Maximal intensity projections (MIPs) were rendered for each image, the boundaries of cells/ neurons of interest (GFP Electrophysiology LTP studies were carried out on hippocampal slices from 6-9 month old mice as previously described (Oddo et al., 2003) . Animals were anesthetized with Isoflurane, decapitated, and brains were rapidly removed in ice-cold ACSF (125 mM NaCl, 2.5 mM KCl, 1.25 mM KH 2 PO 4 , 25 mM NaHCO 3 , 1.2 mM MgSO 4 , 2 mM CaCl 2 , and 10 mM dextrose bubbled with 95% O 2 , 5% CO 2 [pH 7.4]). Coronal hippocampal slices (400 mm) were prepared using a vibratome and left to equilibrate in ACSF at room temperature before recording. Slices were continuously perfused with ACSF. Field excitatory postsynaptic potentials (fEPSCs) were recorded in the stratum radiatum from CA1 using a glass microelectrode. Synaptic responses were evoked by stimulating the Schaffer collateral pathway with a concentric bipolar stimulating electrode with 0.1 ms pulse width. LTP was induced by high-frequency stimulation (HFS) consisting of three trains of 100 Hz stimulation at 20 s intervals. Recordings were made every 30 s for 60 min after HFS. The fEPSP slope was measured offline using Axograph software and were expressed as a percentage of the average slope from the 15 min of baseline recordings. Slices were placed in an interface chamber, continuously perfused with aCSF, and oxygenated with a continuous flow of 95% O 2 , 5% CO 2 ). Field excitatory postsynaptic potentials (fEPSPs) were recorded in the stratum radiatum of the CA1 using glass microelectrodes filled with aCSF. Synaptic responses were evoked by stimulation of the Schaffer collateral/ commissural pathway with a concentric bipolar stimulating electrode with 0.1 ms pulse width. Input/output curves were generated using stimulus intensities from 0 to 500 mA in increments of 50 mA. PPF was assessed using an interstimulus interval of 50 ms. Baseline fEPSPs were evoked at 30% of the max fEPSP for 15 min prior to HFS. LTP was induced at baseline intensity using high-frequency stimulation (HFS) consisting of four trains of 100 Hz stimulation at 20 s intervals. Recordings were made every 30 s for 60 min after HFS. The maximum fEPSP slopes were measured offline using Axograph software and were expressed as a percentage of the average slope from the 15 min of baseline recordings. In some experiments, the stimulus intensity was raised so that baseline EPSP slopes matched the average baseline EPSP in the NonTg mice. LTP was measured as the 55-60 minute fEPSP slope. The researcher conducting recordings was in most cases blind to the genotype of the NgR animal under investigation until post analysis.
Voltage clamp recordings were carried out on acute slices (prepared as described for LTP studies above) or 14-21DIV dissociated hippocampal neurons cultured as described earlier. The extracellular recording solution contains 1 mM AP5, 10 mM CNQX, 1 mM TTX, 30 mM Saclofen, 20 mM bicuculline methiodide, 10 mM TEA-Cl, 130 mM NaCl, 5.4 mM KCl, 0.6mM MgCl 2 , 0.6mM NaH 2 PO 4, 1 mM NaHCO 3, 1.8 mM CaCl 2, 5.5 mM glucose and 10 mM HEPES adjusted to pH 7.4. The intracellular recording solution contains 120 mM tetramethylammonium, 10 mM EGTA, 10 mM Na 2 HPO 4 , 1mM GTP, 2mM ATP and 10 mM HEPES, adjusted to pH 7.2 with hydrofluoric acid. Currents were recorded using a Multiclamp 200B amplifier, Digidata 1320A A/D converter, and Clampex 10.3 software (Molecular Devices, LLC, Sunnyvale, CA, USA). Series resistance and cell capacitance were compensated to the maximal possible extent. All recordings were performed at room temperature. For analyses of inhibitory effects on T-type currents (I/I Baseline), the current recording at the final minute of recording (16-30 minutes) was used. For acute slice recordings of T-type currents, only the left hippocampus (site proximal to ICV injections) was used for recording studies.
ICV Injections in Mice
Vehicle (2% DMSO) or ADDLs (0.8uls or $10 pmol) were stereotaxically delivered to eight to twelve-week-old male mice (NgR WT , NgR HHH or NgR NNN ) under anesthesia to the lateral ventricle (coordinates: AP: À0.90 mm; ML: À1.90 mm; DV: À2.40 mm). Animals showing any signs of pathology (e.g., lethargic, ungroomed) post-injection were excluded from analysis.
Mouse Behavior Studies
In novel object recognition studies ICV injected animals were acclimated in two 20 minute sessions to an open field chamber. Open field movement and animal-object interactions (exploration) were recorded using a portable tripod mounted video camera. Open field analysis was carried during one 10-minute acclimatization session just prior to sample training out using automated software developed in MATLAB (MathWorks; Patel et al., 2014) . Following habituation training, animals were exposed to two identical objects for 5 minutes (sample training). Following a two-hour retention period, animals were exposed to one familiar object and one novel object and videotaped for 5 minutes (test training). Exploration times for each object is expressed as interaction time with one object divided by the total interaction time with both objects. NOR videotaping and subsequent analysis was done by researchers blind to genotype and condition. Animals showing less that 10 s of interaction time with objects over the 5-minute test training session were excluded from analysis (Figueiredo et al., 2013) .
QUANTIFICATION AND STATISTICAL ANALYSIS
All statistical analyses with n are indicated in figure legends and a supplemental data spreadsheet, along with exact numbers. All statistical analyses were carried out using Prism 7 (GraphPad Software).
In spine live imaging studies in hippocampal slice cultures, 3-4 independent experiments were carried out, with up to three imaging sessions (every two days) per locale. Approximately 10-20 locales (each locale from 1 neuron) were imaged per experiment. For analysis, locales clearly visualized at all time points were aligned, and spine density measurements were carried out using NIS Elements. n equals the number of independent experiments. Note, one P6 rat pup was used per condition for each experiment. Significance was assessed either by a paired Student's t test (CON versus ADDL) or one-way ANOVA with Bonferroni posthoc test (shNgR1 ADDL analysis).
For analysis of dendritic spines from ICV injected animals, 10 dendritic segments from 6-10 neurons encompassing at least 100 spines per segment were imaged per animals. Spine criteria was defined based on previous work For analysis of Biotin-LC-Ab staining of heterologous cells transfected with NgR receptors n equals the total number of cells analyzed over 3 independent experiments. Significance was assessed by two-way ANOVA with Dunnett's multiple comparison test.
For sensor imaging analysis, the sensor DF/F of all ROIs of a particular type (shaft, spine, or axon) were averaged for each neuron. n equals the number of neurons analyzed from at least 3 independent experiments. To measure acute or sustained sensor responses following ABeta exposure, 30 s sensor averages were calculated for each ROI in SPSS (IBM). Acute responses to Ab peptides represent the maximum 30 s mean sensor DF/F of ROIs of a particular type from the indicated number of neurons (n). Sustained responses to Ab represent the maximum or minimum 1-minute mean sensor DF/F of ROIs of a particular type from the indicated number of neurons (n). For assessing the statistical significance of sensor data, paired analyses (Student's t test) of maximum mean sensor DF/F data (30 s or 1-minute sensor means) between control and Ab exposure periods was carried out. Note, all example sensor images were maximal intensity projections of 30 s intervals where the maximum or minimum sensor changes were observed. For analysis of global calcium transients, calcium peaks were quantified before and following ADDL exposure (10-15 minutes) and significance assessed in paired Student's t tests with n equal to the number of neurons analyzed.
In LTP studies, n equals the number of animals analyzed. A one-way analysis of variance (ANOVA) with a Tukey's (NgR alleles) or Dunnet's (all other analyses) posthoc test was used to assess significance for all multiple comparison analyses while an unpaired t test was in PPF analysis.
For voltage clamp analysis of T-type current inhibition a paired t test was used to assess statistical significance comparing control baseline currents with current recordings at the final minute of recording (16-30 minutes) with the n equal to the number of neurons recorded. Note neurons were from at least 3 independent experiments.
Average T-type current amplitudes were from recordings of cultured neurons in vitro or acute hippocampal slices in vivo studies. N equals the number of neurons recorded from in vitro (from at least 3 experiments) or animals (acute hippocampal slice) recorded from in vivo. Statistical significance was assessed by one-way ANOVA with Dunnet's multiple comparison test.
In NOR behavioral studies, statistical significance was assessed using an unpaired Student's t test comparing the mean object exploration time with a fixed value of 50% (Figueiredo et al., 2013) .
DATA AND SOFTWARE AVAILABILITY
Analysis software was developed for calcium peak detection in MATLAB (CalciumDetect). The code to run this software is provided in Github (see Key Resources Table) .
